Table of ContentsView AllTable of ContentsAcute HIV InfectionChronic HIV InfectionAIDS-Defining DiseasesNon-HIV-Related Illness

Table of ContentsView All

View All

Table of Contents

Acute HIV Infection

Chronic HIV Infection

AIDS-Defining Diseases

Non-HIV-Related Illness

Although thesigns and symptoms of HIVare largely the same whether you are assigned female or male, there are several specific to women that can occur during early-stage or later-stage infection.

HIV symptoms in women include:

In 2018, of the 1.2 million Americans living with HIV, an estimated 37,832 were women. Of these, 1 in 9 are thought to be unaware of theirHIV status, according to data from the Centers for Disease Control and Prevention (CDC).

Verywell / Michela Buttignol

What Is the Risk of HIV From Vaginal Sex?

Acute HIV infection, also known asacute seroconversion, is the first of three stages of the disease immediately following exposure to the virus. During acute seroconversion, theimmune systemwill produce defensiveantibodiesto help fight the virus and bring the infection under control.

From start to finish, acute seroconversion generally lasts for seven to 14 days, during which some people may experience symptoms (referred to asacute retroviral syndrome, or ARS). Symptoms are typically described as being flu-like with mild fever and body ache.Swollen lymph nodesandrashmay also accompany.

As many as 43% of people will not experience any signs of acute HIV infection, according to a 2016 study inEmerging Infectious Diseases.

Disparities in Infection Rates

When acute symptoms develop, they are generally the same in women as they are in men. Where they do vary is the rate of seroconversion.

Heterosexual women are twice as likely to get infected per sexual act compared to heterosexual men (due in part to the increased size and porosity of vaginal tissues compared to those of the penis).

These and other factors confer higher rates of new infections among women compared to men—and also translates to faster disease progression.

According to a 2014 review in theJournal of Infectious Diseases,women with HIV have a 1.6-fold greater risk of progressing to AIDS (the most advanced stage of the disease) than men.

HIV Statistics You Should Know

HIV and STD Co-Infection

Other symptoms may develop during acute seroconversion if there an accompanyingsexually transmitted disease (STD). Studies suggest that 1 in 7 people with HIV are co-infected with another STD at the time of their diagnosis.Other studies suggest theHIV/STD co-infectionrate may be even higher.

These infections undermine the barrier function of the vaginal mucosa and increase the concentration of immune cells at the site of the infection. Among them areCD4 T-cells, the very cells that HIV preferentially targets.

It is for this reason that the CDC recommendsHIV testingfor anyone who seeks thediagnosisandtreatmentof an STD.

Does Menstruation Increase a Woman’s Risk of HIV?

HIV Doctor Discussion GuideGet our printable guide for your next doctor’s appointment to help you ask the right questions.Download PDFEmail AddressSign UpThank you, {{form.email}}, for signing up.There was an error. Please try again.

Get our printable guide for your next doctor’s appointment to help you ask the right questions.

Woman Doctor Discussion Guide

Download PDF

Email AddressSign UpThank you, {{form.email}}, for signing up.There was an error. Please try again.

Sign Up

Thank you, {{form.email}}, for signing up.

There was an error. Please try again.

This chronic stage of infection, referred to as clinical latency, is one in which the infection may progress silently with few notable symptoms. Even so, the virus will continue to infect and deplete CD4 T-cells that the body relies on to fight disease.

Over time, the loss of CD4 T-cells will lead toimmunosuppressionand an increased risk of opportunistic infections (OIs). They are considered “opportunistic” because an intact immune system would control them.

A CD4 count between 500 to 1,200 cells per cubic millimeter (cells/mm3) is considered normal. Any value between 250 and 500 cells/mm3 is a threshold for defining immunosuppression.

Barriers to Boosting CD4 Counts

Signs and Complications in Women

The symptoms of chronic HIV infection are related to the development of OIs. With that said, secondary conditions affecting a woman’s fertility and menstrual cycle can develop as a result of prolonged immune suppression and chronic inflammation.

The type of OIs commonly seen at CD4 counts between 250 and 500 are more or less the same in females and males. These includeherpes simplex,herpes zoster(shingles), bacterial pneumonia,bacterialandfungal skin infections,tuberculosis, and HIV-associatedmeningitis.

The differences, in any, mainly involve a woman’s reproductive tract. The symptoms may include:

In addition to symptoms, women with HIV will often experience changes that are only recognized during apelvic exam. This may include anabnormal PAP smearor signs ofcervical dysplasia(a precancerous condition affecting the cervix).

Aging Types, Causes, and Prevention

AIDS

Without the means to defend yourself from common and uncommon diseases, AIDS runs a high risk of severe and potentially life-threatening illness. These include infections and certain types of cancers as well.

According to the CDC, a person is said to have progressed to AIDS when:

AIDS-defining conditions include disease are rarely seen among people who have a healthy immune system. They also involve common OIs that have disseminated (spread) from their typical site of infection to other parts of the body.

According to the CDC, the median time of progression from initial HIV infection to AIDS is 11 years if the condition is not treated.

Does HIV Always Progress to AIDS?

Symptoms of AIDS in Women

The symptoms of AIDS vary little between women and men. There are some variations, including evidence that women with HIV experience greater cognitive decline and may be more likely to experience signs of HIV encephalopathy (a.k.a. AIDS dementia complex) than men.

The one AIDS-defining condition exclusive to women is invasive cervical cancer (ICC). This is the advanced stage of cervical cancer in which tumor cells have spread to tissues deeper within the cervix or to other parts of the body. Though ICC can affect both HIV-positive and HIV-negative women, the incidence among women with HIV is up to seven times greater.

As with other HIV-associated conditions, the risk of ICC increases with declines in the CD4 count. Women with CD4 counts under 200 are six times more likely to get ICC than those whose CD4 counts over 500.

Arguably more concerning is the fact that the incidence of ICC among women with HIV has remained largely unchanged since the 1990s. This is unlike other AIDS-defining conditions that are rarely seen today due to the advent ofcombination antiretroviral therapy.

In addition to HIV-related conditions, there are a number of non-HIV-related illnesses commonly seen in people with long-term infection. These include cancers and aging-related diseases that develop an average of 10 to 15 years earlier in people with HIV than those without.

Under the burden of chronic inflammation, the body tissues can undergo changes that literally age them, leading to a phenomenon knows as premature senescence. Particularly if left untreated, HIV can increase the risk of non-HIV-related cancers and cardiovascular diseases, including heart attacks and strokes.

In some cases, women are disproportionately affected. Studies suggest, for instance, that women with HIV have a higher risk of heart disease than men due to the activation of white blood cells calledmonocytesthat promote cardiovascular inflammation.

Similarly, women with HIV who engage in anal sex are at increased risk ofanal cancer(due to HPV co-infection). While anal cancer is relatively rare in the United State, women with HIV are 30 times more likely to be affected than women in the general population.

Non-AIDS-defining cancers are the leading cause of death in people with HIV in the developed world, according to research published in theJournal of the International AIDS Society.

Pictures of HIV Mouth Sores

A Word From Verywell

Although certain symptoms may suggest you have HIV, the absence of symptoms should not be considered an all-clear flag. Today, an estimated 1 in 7 Americans living with HIV remain undiagnosed, either because they have no idea they have been infected or are ignoring their suspicions.

The U.S. Preventive Services Task Force currently recommends at least one HIV test for all Americans 15 to 65 as part of a routine medical exam.If you haverisk factors for HIVand have not been tested, there may be no better time to do so than now.

How HIV Is Treated

29 Sources

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

Hoenigl M, Green N, Camacho M, et al.Signs or symptoms of acute HIV infection in a cohort undergoing community-based screening.Emerg Infect Dis. 2016 Mar;22(3):532-4. doi:10.3201/eid2203.151607

Scully EP.Sex differences in HIV infection.Curr HIV/AIDS Rep. 2018;15(2):136-46. doi:10.1007/s11904-018-0383-2

Centers for Disease Control and Prevention.Fast facts: HIV and women.

Addo MM, Altfeld M.Sex-based differences in HIV type 1 pathogenesis.J Infect Dis. 2014 Jul 15;209(Suppl 3):S86–S92. doi:10.1093/infdis/jiu175

Kalichman SC, Pellowski J, Turner C.Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: Systematic review with implications for using HIV treatments for prevention.Sex Transm Infect.2011 Apr;87(3):183–90. doi:10.1136/sti.2010.047514

Chen MJ, Scheer S, Nguyen TQ, Kohn KP, Schwarcz SK.HIV coinfection among persons diagnosed as having sexually transmitted diseases, San Francisco, 2007 to 2014.Sex Transm Dis.2018 Aug;45(8):563-72. doi:10.1097/OLQ.0000000000000789

Dionne-Odom J, Westfall AO, Van Der Pol B, Fry K, Marrazzo J.Sexually transmitted infection prevalence in women with HIV: Is there a role for targeted screening?.Sex Transm Dis.2018 Nov;45(11):762–9. doi:10.1097/OLQ.0000000000000852

Centers for Disease Control and Prevention.About HIV.

MedlinePlus.CD4 lymphocyte count.

Zanoni BC, Gandhi RT.Update on opportunistic infections in the era of effective antiretroviral therapy.Infect Dis Clin North Am. 2014 Sep;28(3):501–18. doi:10.1016/j.idc.2014.05.002

Apalata T, Carr WH, Sturm WA, Longo-Mbenza B, Moodley P.Determinants of symptomatic vulvovaginal candidiasis among human immunodeficiency virus type 1 infected women in Rural KwaZulu-Natal, South Africa.Infect Dis Obstet Gynecol. 2014;2014:387070. doi:10.1155/2014/387070

Lagnese M, Daar ES, Christenson P, Rieg C.Herpes simplex virus type 2 seroprevalence and incidence in acute and chronic HIV-1 infection.Int J STD AIDS. 2011 Aug;22(8):463-4. doi:10.1258/ijsa.2011.010551

Yalamanchi S, Dobs A, Greenblatt RM.Gonadal function and reproductive health in women with HIV infection.Endocrinol Metab Clin North Am. 2014 Sep;43(3):731–41. doi:10.1016/j.ecl.2014.05.002

Savasi V, Antonazza P, Personeni C.Heterotopic pregnancy in HIV women.SAGE Open Med Case Rep. 2016;4:2050313X16679534. doi:10.1177/2050313X16679534

De Pommerol M, Hessamfar M, Lawson-Ayayi S, et al.Menopause and HIV infection: Age at onset and associated factors, ANRS CO3 Aquitaine cohort.Int J STD AIDS. 2011 Feb;22(2):67-72. doi:10.1258/ijsa.2010.010187

Finnerty F, Walker-Bone K, Tariq S.Osteoporosis in postmenopausal women living with HIV.Maturitas.2017 Jan;95:50–54. doi:10.1016/j.maturitas.2016.10.015

World Health Organization.5. Screening and treatment of cervical pre-cancer. In: Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd edition. 2014.

U.S. Department of Health and Human Services HIV.gov.What are HIV and AIDS?.

Maki PM, Rubin LH, Springer G, et al.Differences in cognitive function between women and men With HIV.J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):101-7. doi:10.1097/QAI.0000000000001764

Abraham A, D’Souza G, Jing Y, et al.Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration.J Acquir Immune Defic Syndr.2013 Apr 1; 62(4):405-13. doi:10.1097/QAI.0b013e31828177d7

McKenzie ND, Kobetz EN, Hnatyszyn J, Twiggs LB, Lucci JA.Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types,Gynecol Oncol. 2010 Mar;116(3):572-7. doi:10.1016/j.ygyno.2009.10.058

Pirrone V, Libon DJ, Sell C, Lerner CA, Nonnemacher MR, Wigdahl B.Impact of age on markers of HIV-1 disease.Future Virol. 2013 Jan;8(1):81–101. doi:10.2217/fvl.12.127

American Heart Association.As HIV patients live longer, heart disease might be their next challenge.

Wang CCJ, Sparano J, Palefsky JM.HIV/AIDS, HPV and anal cancer.Surg Oncol Clin N Am. 2017 Jan;26(1):17–31.

Hleyhel M, Belot A, Bouvier A, et al.Risk of AIDS-defining cancers in HIV-1 infected patients (1992-2009): results from FHDH-ANRS CO4.J Int AIDS Soci.2012;15(4):1-2. doi:10.7448/IAS.15.6.18196

HIV.gov.U.S. statistics.

Insight START Study Group.Initiation of antiretroviral therapy in early asymptomatic HIV infection.N Engl J Med.2015 Aug 27; 373:795-807. doi:10.1056/NEJMoa1506816

U.S. Preventive Services Task Force.Final recommendation statement: Human immunodeficiency virus (HIV) infection: Screening.

Meet Our Medical Expert Board

Share Feedback

Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit

Was this page helpful?

Thanks for your feedback!

What is your feedback?OtherHelpfulReport an ErrorSubmit

What is your feedback?

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.Cookies SettingsAccept All Cookies

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookies SettingsAccept All Cookies